Related Experiment Video
Updated: May 25, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling
Ilkka Paatero1, Anne Jokilammi2, Pekka T Heikkinen3
1Department of Medical Biochemistry and Genetics, and MediCity Research Laboratory, University of Turku, FI-20520 Turku, Finland,; Turku Doctoral Programme of Biomedical Sciences, FI-20520 Turku, Finland.
The Journal of Biological Chemistry
|February 7, 2012
Summary
The ErbB4 receptor tyrosine kinase stabilizes hypoxia-inducible factor-1α (HIF-1α) by preventing its degradation. This novel mechanism impacts cancer cell survival and HIF-1α target gene expression.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Cancer Research
Background:
- Hypoxia-inducible factor-1α (HIF-1α) is a key regulator of cellular response to low oxygen.
- Dysregulation of HIF-1α signaling is implicated in various cancers.
Purpose of the Study:
- To investigate the role of ErbB4 in regulating HIF-1α signaling.
- To elucidate the mechanism by which ErbB4 affects HIF-1α stability.
Main Methods:
- Co-immunoprecipitation to assess protein interactions.
- Western blotting to evaluate protein levels and degradation.
- Reporter assays to measure transcriptional activity.
- In vivo studies using genetically modified mice.
- Analysis of human tissue samples.
Main Results:
- ErbB4 directly interacts with HIF-1α in the nucleus, stabilizing it against proteasomal degradation.
- HIF stabilization by ErbB4 is independent of VHL and proline hydroxylation but dependent on RACK1.
- ErbB4 activity is crucial for HIF-1α target gene transcription and mammary carcinoma cell survival.
- Targeting ErbB4 in mice reduces HIF-1α levels in vivo.
- ERBB4 expression correlates with HIF-regulated genes in human tissues.
Conclusions:
- The intracellular domain of ErbB4 is a novel regulator of HIF-1α stability and signaling.
- ErbB4-mediated HIF-1α stabilization represents a potential therapeutic target in cancer.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.